Dr. Yvonne Saenger: Crushing Cancer’s Defenses
For about a decade, large clinical trials of cancer vaccine candidates have turned out mostly disappointing. But now a handful of new therapies are showing signs that the cancer vaccine effort could be on the brink of big breakthroughs. However, few melanoma vaccines have lived up to expectations, says Dr. Yvonne Saenger, a melanoma specialist at Mount Sinai School of Medicine in New York City. The drug MAGE-A3 may or may not be different, she says. She is waiting to see the Phase III results before weighing in. Learn more
Mount Sinai Study Finds Lung Cancer Surgery Safe for Many Patients Over 80
Apr 02, 2026 View All Press Releases
Mount Sinai Study May Help Cancer Patients Keep Their Bladder
Feb 19, 2026 View All Press Releases
